Product
Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
1 clinical trial
2 indications
Indication
Treatment-naïveIndication
Peripheral T Cell LymphomaClinical trial
Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of Liposomal Mitoxantrone Hydrochloride Injection Combined With Cyclophosphamide, Vincristine and Prednisone in the Treatment of Untreated PTCLStatus: Terminated, Estimated PCD: 2023-06-30